Skip to main content
Toggle navigation
Login
Search
Home
Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Email
Tweet
Print
Charles Dharmani, DrPH, Pharm D, MPH, MS (he/him/his)
Senior Director, Epidemiology, Clinical Safety & Pharmacovigilance
Daiichi Sankyo Inc.
Poster(s):
(P 199) PEXIDARTINIB RISK EVALUATION AND MITIGATION STRATEGY PROGRAM: 3-YEAR SAFETY DATA ASSESSMENT
(P 200) EPIDEMIOLOGY OF TENOSYNOVIAL GIANT CELL TUMOR IN THE UNITED STATES
Email Charles